Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
- Sponsored Content
- Analytical
Data-Driven Decisions to Maximize Productivity Using Automated Immunoassays in Clone and Bioprocess DevelopmentData-Driven Decisions to Maximize Productivity Using Automated Immunoassays in Clone and Bioprocess Development
Helena Nilshans
August 18, 2015
1 Min Read
Sponsored by Gyros
High productivity in bioprocess development demands efficient bioanalytical procedures to measure clone expression, product titer, and process impurities. Commonly used methods such as enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography (HPLC) can create bottlenecks in critical workflows due to limitations in throughput, performance, and time to results.
Read the full text of this application note in the PDF (Login required).
You May Also Like
Mar 18 - Mar 21, 2025
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn MoreInnovative Technology
Sponsored Content
